ストックスクリーナーアプリを入手
19.00
20.93%
-5.03
アフターアワーズ：
19.01
0.01
+0.05%
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
Amphastar Pharmaceuticals Q1 2026 10-Q: Financial Results, Risk Factors, and Forward-Looking Statements - Minichart
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap DownWhat's Next? - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Amphastar Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
Why Amphastar Pharmaceuticals (AMPH) Is Up 9.4% After Profit Squeeze Despite Flat Q1 2026 Sales - simplywall.st
Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 CY2026 Sales Expectations, Stock Drops - Yahoo Finance
Profit falls as costs rise at Amphastar (NASDAQ: AMPH) in Q1 2026 - Stock Titan
Amphastar: Q1 Earnings Snapshot - kare11.com
Amphastar held sales at $171M, but profit fell on higher costs - Stock Titan
Earnings slide at Amphastar (NASDAQ: AMPH) despite steady Q1 revenue - Stock Titan
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 - Bluefield Daily Telegraph
MSN Money - MSN
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference - Black Hills Pioneer
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Amphastar Pharmaceuticals Faces Downgrade Despite Strong Annual Revenue - HarianBasis.co
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026 - Black Hills Pioneer
Jefferies Downgrades Amphastar Pharmaceuticals (AMPH), Cites Lack of Meaningful Upside Catalysts - Insider Monkey
Amphastar: A Cheap Multiple Doing Exactly What It's Supposed To Do (NASDAQ:AMPH) - Seeking Alpha
After-close Q1 results: Amphastar schedules May 7 investor call - Stock Titan
Are investors undervaluing Amphastar Pharmaceuticals (AMPH) right now? - MSN
Amphastar outlines key launches and product growth drivers for 2025 - MSN
Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance Australia
Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now? - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) to Release Earnings on Wednesday - MarketBeat
Do options traders know something about Amphastar Pharmaceuticals stock we don't? - MSN
AMPH Price Today: Amphastar Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Amphastar reports FDA approval for teriparatide injection - MSN
Boston Trust Walden Corp Reduces Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals Downgrade: Stock Falls After Analyst MoveNews and Statistics - IndexBox
Jefferies downgrades Amphastar Pharmaceuticals (AMPH) - MSN
Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding Today - Yahoo Finance
Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Down 7.4%Time to Sell? - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Earns Hold Rating from Jefferies Financial Group - MarketBeat
Why (AMPH) Price Action Is Critical for Tactical Trading - Stock Traders Daily
1.49%
1.78%
大文字化:
|
ボリューム (24 時間):